Gilead Sciences (GILD) FY2024 results: revenue $28.8 billion, up 6.0% on the year
Gilead Sciences, Inc. (GILD) reported revenue of $28.8 billion for fiscal 2024, the year ended 31 December 2024, up 6.0% on the year before. Net income was $480 million, down 91.5%, and diluted earnings per share $0.38. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2025.
Revenue
$28.8 billion
+6.0% on the year
FY2017FY2024
Operating margin
5.8%
28.0% a year earlier
FY2017FY2024
Net income
$480 million
-91.5% on the year
FY2017FY2024
Diluted EPS
$0.38
-91.6% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
10,828
8,006
9,072
+35.2%
Capital expenditure
523
585
728
-10.6%
Free cash flow
10,305
7,421
8,344
+38.9%
Free cash flow margin
35.8%
27.4%
30.6%
Cash from investing
-3,449
-2,265
-2,466
Cash from financing
-3,433
-5,125
-6,469
Depreciation and amortisation
2,781
2,654
2,123
+4.8%
Share-based compensation
835
766
637
+9.0%
Buybacks
1,150
1,000
1,396
+15.0%
Dividends paid
3,918
3,809
3,709
+2.9%
Dividend per share
$3.08
$3.00
$2.92
+2.7%
Diluted shares, weighted
1,255m
1,258m
1,262m
-0.2%
Shares outstanding at period end
1,246m
1,246m
1,247m
0.0%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
19,330
22,833
21,240
-15.3%
Non-controlling interest
-84.0
-84.0
-31.0
Debt
26,710
24,987
25,229
+6.9%
Operating lease liabilities
498
546
467
-8.8%
Other liabilities
12,541
13,843
16,266
-9.4%
Total liabilities and equity
58,995
62,125
63,171
-5.0%
Fixed assets
5,414
5,317
5,475
+1.8%
Goodwill
8,314
8,314
8,314
0.0%
Intangible assets
19,948
26,454
28,894
-24.6%
Investments
0.0
2,342
2,218
Cash and equivalents
9,991
6,085
5,412
+64.2%
Receivables
4,420
4,660
4,777
-5.2%
Inventory
1,710
1,787
1,507
-4.3%
Other assets
9,198
7,166
6,574
+28.4%
Total assets
58,995
62,125
63,171
-5.0%
10-K for the year ended 31 December 2024, filed 28 February 2025: the filing.